Ideaya Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ideaya Biosciences Stock Summary

Ideaya Biosciences competes with AnaptysBio, MeiraGTx Holdings, Keros Therapeutics, Ventyx Biosciences, and Protagonist Therapeutics. IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Ideaya Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 91 people.

Ideaya Biosciences Key Financial Ratios

Ideaya Biosciences Key Balance Sheet Accounts

Ideaya Biosciences Key Income Statement Accounts

Ideaya Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ideaya Biosciences's current stock value. Our valuation model uses many indicators to compare Ideaya Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ideaya Biosciences competition to find correlations between indicators driving Ideaya Biosciences's intrinsic value. More Info.Ideaya Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Ideaya Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ideaya Biosciences' earnings, one of the primary drivers of an investment's value.

Ideaya Biosciences Systematic Risk

Today, most investors in Ideaya Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ideaya Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ideaya Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ideaya Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ideaya Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ideaya Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Ideaya Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ideaya Biosciences's daily price indicators and compare them against related drivers.

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.